What We're Reading: Aetna Sells Part D Business; CMS Defends Work Requirements; TB Vaccine Shows Promise
Aetna is selling its Medicare Part D prescription drug unit to WellCare Health Plans; Seema Verma, administrator of CMS, defended Medicaid work requirements, saying they are not intended to kick people out of the program; an experimental tuberculosis (TB) vaccine demonstrated 54% protection in a clinical trial.
Aetna Selling Part D Drug Business to Prepare for CVS Deal
Aetna is selling its Medicare Part D prescription drug unit to WellCare Health Plans,
CMS Chief Defends Medicaid Work Requirements
Seema Verma, administrator of CMS, said Medicaid work requirements are not intended to kick people out of the program, according to
Experimental TB Vaccine Shows Promise in Clinical Trial
An experimental tuberculosis (TB) vaccine demonstrated 54% protection in a clinical trial,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025